{"id":2844,"date":"2026-05-27T07:16:04","date_gmt":"2026-05-27T14:16:04","guid":{"rendered":"https:\/\/xpharma.com.cn\/?p=2844"},"modified":"2026-05-27T08:05:15","modified_gmt":"2026-05-27T15:05:15","slug":"raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review","status":"publish","type":"post","link":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/","title":{"rendered":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Onradivir granules (generic name: Onradivir, research code: ZSP1273)<\/strong>\u00a0are a Class 1 chemical innovative drug independently developed by Raynovent in Guangdong, China, and represent the world&#8217;s first pediatric formulation of an influenza A virus RNA polymerase PB2 inhibitor. On May 22, 2025, Onradivir tablets (adult formulation) was approved for marketing, becoming the world&#8217;s first PB2-targeted anti-influenza drug. Its Phase III clinical data were published in\u00a0<em>The Lancet Respiratory Medicine<\/em>, receiving international authoritative recognition. The development of a granule formulation for the pediatric population progressed in parallel. On February 9, 2026, the topline data from the Phase III clinical trial of Onradivir granules for the treatment of uncomplicated influenza A in children aged 2\u201311 years were announced. On May 14, 2026, the New Drug Application (NDA) was accepted by the NMPA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Onradivir granules (generic name: Onradivir, research code: ZSP1273)\u00a0are a Class 1 chemical innovative drug independently developed by Raynovent in Guangdong, China, and represent the world&#8217;s first pediatric formulation of an influenza A virus RNA polymerase PB2 inhibitor. On May 22, 2025, Onradivir tablets (adult formulation) was approved for marketing, becoming the world&#8217;s first PB2-targeted anti-influenza [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2846,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-2844","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China<\/title>\n<meta name=\"description\" content=\"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent\uff1aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China\" \/>\n<meta property=\"og:description\" content=\"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent\uff1aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/\" \/>\n<meta property=\"og:site_name\" content=\"Xpharma China\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/61590027634719\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T14:16:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-27T15:05:15+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"420\" \/>\n\t<meta property=\"og:image:height\" content=\"310\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"xpharmanews\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:site\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"xpharmanews\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/\"},\"author\":{\"name\":\"xpharmanews\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\"},\"headline\":\"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review\",\"datePublished\":\"2026-05-27T14:16:04+00:00\",\"dateModified\":\"2026-05-27T15:05:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/\"},\"wordCount\":133,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo.png\",\"articleSection\":[\"Approved News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/\",\"name\":\"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo.png\",\"datePublished\":\"2026-05-27T14:16:04+00:00\",\"dateModified\":\"2026-05-27T15:05:15+00:00\",\"description\":\"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo.png\",\"width\":420,\"height\":310},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/2026\\\/05\\\/27\\\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/xpharma.com.cn\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"name\":\"Xpharma China - International Pharmaceutical wholesaler and retailer\",\"description\":\"Xpharma China\",\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xpharma.com.cn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\",\"name\":\"Xpharma China\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"width\":679,\"height\":166,\"caption\":\"Xpharma China\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/61590027634719\\\/\",\"https:\\\/\\\/x.com\\\/Xpharma007\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\",\"name\":\"xpharmanews\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"caption\":\"xpharmanews\"},\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/author\\\/xpharmanews\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China","description":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent\uff1aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/","og_locale":"en_US","og_type":"article","og_title":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China","og_description":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China","og_url":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent\uff1aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/","og_site_name":"Xpharma China","article_publisher":"https:\/\/www.facebook.com\/61590027634719\/","article_published_time":"2026-05-27T14:16:04+00:00","article_modified_time":"2026-05-27T15:05:15+00:00","og_image":[{"width":420,"height":310,"url":"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/logo.png","type":"image\/png"}],"author":"xpharmanews","twitter_card":"summary_large_image","twitter_creator":"@Xpharma007","twitter_site":"@Xpharma007","twitter_misc":{"Written by":"xpharmanews","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#article","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/"},"author":{"name":"xpharmanews","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05"},"headline":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review","datePublished":"2026-05-27T14:16:04+00:00","dateModified":"2026-05-27T15:05:15+00:00","mainEntityOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/"},"wordCount":133,"commentCount":0,"publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/logo.png","articleSection":["Approved News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/","url":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/","name":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#primaryimage"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/logo.png","datePublished":"2026-05-27T14:16:04+00:00","dateModified":"2026-05-27T15:05:15+00:00","description":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review - Xpharma China","breadcrumb":{"@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#primaryimage","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/logo.png","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/logo.png","width":420,"height":310},{"@type":"BreadcrumbList","@id":"https:\/\/xpharma.com.cn\/index.php\/2026\/05\/27\/raynovent%ef%bc%9aclass-1-innovative-drug-onradivir-granules-included-in-priority-review\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/xpharma.com.cn\/"},{"@type":"ListItem","position":2,"name":"Raynovent\uff1aClass 1 innovative drug Onradivir Granules included in priority review"}]},{"@type":"WebSite","@id":"https:\/\/xpharma.com.cn\/#website","url":"https:\/\/xpharma.com.cn\/","name":"Xpharma China - International Pharmaceutical wholesaler and retailer","description":"Xpharma China","publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xpharma.com.cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/xpharma.com.cn\/#organization","name":"Xpharma China","url":"https:\/\/xpharma.com.cn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","width":679,"height":166,"caption":"Xpharma China"},"image":{"@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/61590027634719\/","https:\/\/x.com\/Xpharma007"]},{"@type":"Person","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05","name":"xpharmanews","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","caption":"xpharmanews"},"url":"https:\/\/xpharma.com.cn\/index.php\/author\/xpharmanews\/"}]}},"_links":{"self":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/2844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/comments?post=2844"}],"version-history":[{"count":2,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/2844\/revisions"}],"predecessor-version":[{"id":2850,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/2844\/revisions\/2850"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media\/2846"}],"wp:attachment":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media?parent=2844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/categories?post=2844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/tags?post=2844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}